Industry Insight
Discovery Technology
Analytical Laboratory Technology
Biopharma
Manufacturing
Delivery Systems
Ingredients, Formulation and Finishing
Bioprocessing
View our other publications with free access to extensive archives
  To print this article:
Existing subscribers please log in:
 
  USER NAME  
  PASSWORD  
   Or select

Or become a subscriber
 
 
 

The end of gelatine?

A capsule-forming technology has been developed which not only eliminates the use of gelatine, but also paves the way for the development of novel pharmaceutical formulations.

Graham Hind, BioProgress Technology Ltd (January 2001)

Keywords: homogenisors, formulation & finishing, fluid bed processing, hard capsules, syringes, tablet, tabletting, transdermal drug delivery, inhalation technologies, injectables, polymer delivery systems, polymer drug delivery, inhalation, injection, lipid, soft capsules, nasal delivery, silicone based delivery systems, powders, sachets, separation, formulation, gelatine, capsule-forming, novel pharmaceutical formulations, BioProgress Technology Ltd

    View full article    |    Back to Ingredients, Formulations and Finishing section




Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | info@iptonline.com | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |